6
Supplemental Figure 1. A. GCN1L1 B. DSP C. RCN3 D. AKR1B10 E. PDIA4 F. CTSB

Supplemental Figure 1

  • Upload
    zora

  • View
    29

  • Download
    0

Embed Size (px)

DESCRIPTION

Supplemental Figure 1. A. GCN1L1. B. DSP. C. RCN3. D. AKR1B10. E. PDIA4. F. CTSB. Supplemental Figure 1. Cont. G. EIF5A. H. SERPINB5. I. TPD52. Supplemental Figure 2. A. Biological process. B. Cellular component. Supplemental Figure 3. A. C. B. A549. Cont. Sh1. Cont. Sh1. - PowerPoint PPT Presentation

Citation preview

Page 1: Supplemental Figure  1

Supplemental Figure 1.

A. GCN1L1 B. DSP C. RCN3

D. AKR1B10 E. PDIA4 F. CTSB

Page 2: Supplemental Figure  1

Supplemental Figure 1. Cont.

G. EIF5A H. SERPINB5 I. TPD52

Page 3: Supplemental Figure  1

Supplemental Figure 2.

A. Biological process B. Cellular component

Page 4: Supplemental Figure  1

Ab

s.

46

0- 6

90

Days

A.

Supplemental Figure 3.

D.

Sh1 Cont

B. C.

No FBS 10%FBS10%FBS

+1uM IPA310%FBS

+10uM IPA3 No FBS 10%FBS10%FBS

+1uM IPA310%FBS

+10uM IPA3

E.

Num

ber

of c

ells

Sh1 Cont

A549

a-PAK2

a-bactin

Num

ber

of c

ells

Page 5: Supplemental Figure  1

164 candidates

12 candidates tested with commercial

Elisa

15 controls15 SCC15 ADC

30 candidates tested with commercial and

in house-ELISAs

6 candidates45 ADC

49 controls

9 candidates41 SCC

34 controls

15 controls15 SCC15 ADC

Supplemental Figure 5Supplemental Table 11

Supplemental Table 12-15

Supplemental Figure 4.

Page 6: Supplemental Figure  1

Supplemental Figure 5.